Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$27,000.00

The role of proximal tubule claudins -2 and -12 in kidney stone formation and response to thiazide diuretics

FY 2024-25

Summary
Kidney stones are mineral deposits within the kidneys or urinary tract that cause pain (often requiring medical or surgical intervention) and increase the risk for a range of other conditions including kidney and cardiovascular disease. Given that >85% of kidney stones are composed of calcium, the greatest risk factor for kidney stone formation is hypercalciuria, which is the production of urine with increased calcium content. Thiazide diuretics are a common therapy for hypercalciuric kidney stone formers however, their efficacy has recently been called into question by a randomized clinical trial. Hypercalciuria commonly results from a failure to reabsorb calcium along the nephrons in the kidneys. Claudin-2 and claudin-12 are pore-forming proteins that facilitate calcium reabsorption from the proximal tubule segment of the nephrons. Recently, we have identified rare novel variants in claudin-2 and claudin-12 that occur with increased frequency in patients with hypercalciuric kidney stones We hypothesize that genetic variations in claudin-2 and claudin-12 cause hypercalciuria and an increased risk of kidney stone formation, and that individuals harbouring these variants are resistant to thiazide diuretics. To investigate this, we will first employ both cell and animal models to characterize the functional impact of these genetic variations on calcium handling. We will then assess the efficacy of thiazides in mouse models with altered expression of claudin-2 and claudin-12 to establish if these genes are required for the effects of thiazides. Overall, we are aiming to provide rationale for employing different therapies for patients with different genetic variants in order to move towards precision medicine for kidney stone formers.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529949
Name
Zhao Peter W
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of proximal tubule claudins -2 and -12 in kidney stone formation and response to thiazide diuretics
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Calcium; Claudins; Genetic Variants; Hypercalciuria; Kidney Stones; Paracellular Transport; Precision Medicine; Proximal Tubule; Thiazides; Tight Junctions
Abstract
Kidney stones are mineral deposits within the kidneys or urinary tract that cause pain (often requiring medical or surgical intervention) and increase the risk for a range of other conditions including kidney and cardiovascular disease. Given that >85% of kidney stones are composed of calcium, the greatest risk factor for kidney stone formation is hypercalciuria, which is the production of urine with increased calcium content. Thiazide diuretics are a common therapy for hypercalciuric kidney stone formers however, their efficacy has recently been called into question by a randomized clinical trial. Hypercalciuria commonly results from a failure to reabsorb calcium along the nephrons in the kidneys. Claudin-2 and claudin-12 are pore-forming proteins that facilitate calcium reabsorption from the proximal tubule segment of the nephrons. Recently, we have identified rare novel variants in claudin-2 and claudin-12 that occur with increased frequency in patients with hypercalciuric kidney stones We hypothesize that genetic variations in claudin-2 and claudin-12 cause hypercalciuria and an increased risk of kidney stone formation, and that individuals harbouring these variants are resistant to thiazide diuretics. To investigate this, we will first employ both cell and animal models to characterize the functional impact of these genetic variations on calcium handling. We will then assess the efficacy of thiazides in mouse models with altered expression of claudin-2 and claudin-12 to establish if these genes are required for the effects of thiazides. Overall, we are aiming to provide rationale for employing different therapies for patients with different genetic variants in order to move towards precision medicine for kidney stone formers.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhao, Peter W
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~